Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

v3.24.2.u1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Treasury Stock
Total
Balance at Mar. 31, 2022 $ 15 $ 946,969 $ (952,583) $ (2,088) $ (7,687)
Balance (in shares) at Mar. 31, 2022 15,398,368     101,633  
Increase (Decrease) in Stockholders' Equity          
Vested restricted stock awards   36   $ (36)  
Vested restricted stock awards (in shares) 33,234     9,296  
Stock-based compensation   232     232
Net Income (Loss)     (4,200)   (4,200)
Balance at Jun. 30, 2022 $ 15 947,237 (956,783) $ (2,124) (11,655)
Balance (in shares) at Jun. 30, 2022 15,431,602     110,929  
Balance at Mar. 31, 2022 $ 15 946,969 (952,583) $ (2,088) (7,687)
Balance (in shares) at Mar. 31, 2022 15,398,368     101,633  
Increase (Decrease) in Stockholders' Equity          
Net Income (Loss)         (7,853)
Balance at Sep. 30, 2022 $ 18 954,750 (960,533) $ (2,139) (7,904)
Balance (in shares) at Sep. 30, 2022 18,449,567     117,014  
Balance at Jun. 30, 2022 $ 15 947,237 (956,783) $ (2,124) (11,655)
Balance (in shares) at Jun. 30, 2022 15,431,602     110,929  
Increase (Decrease) in Stockholders' Equity          
Vested restricted stock awards   15   $ (15)  
Vested restricted stock awards (in shares) 28,882     6,085  
Stock-based compensation   154     154
Stock awards to Board of Directors (in shares) 54,585        
Issuance of common stock, net of issuance costs $ 3 7,247     7,250
Issuance of common stock, net of issuance costs (in shares) 2,934,498        
Deemed dividend on purchase warrant for common shares   97 (97)    
Net Income (Loss)     (3,653)   (3,653)
Balance at Sep. 30, 2022 $ 18 954,750 (960,533) $ (2,139) (7,904)
Balance (in shares) at Sep. 30, 2022 18,449,567     117,014  
Balance at Mar. 31, 2023 $ 18 955,228 (977,202) $ (2,139) $ (24,095)
Balance (in shares) at Mar. 31, 2023 18,511,555     117,014 18,511,555
Increase (Decrease) in Stockholders' Equity          
Vested restricted stock awards   11   $ (11)  
Vested restricted stock awards (in shares) 39,923     8,771  
Stock-based compensation   306     $ 306
Net Income (Loss)     (5,679)   (5,679)
Balance at Jun. 30, 2023 $ 18 955,545 (982,881) $ (2,150) (29,468)
Balance (in shares) at Jun. 30, 2023 18,551,478     125,785  
Balance at Mar. 31, 2023 $ 18 955,228 (977,202) $ (2,139) $ (24,095)
Balance (in shares) at Mar. 31, 2023 18,511,555     117,014 18,511,555
Increase (Decrease) in Stockholders' Equity          
Net Income (Loss)         $ (11,566)
Balance at Sep. 30, 2023 $ 19 955,630 (988,768) $ (2,154) $ (35,273)
Balance (in shares) at Sep. 30, 2023 19,167,971     129,515 19,167,971
Balance at Jun. 30, 2023 $ 18 955,545 (982,881) $ (2,150) $ (29,468)
Balance (in shares) at Jun. 30, 2023 18,551,478     125,785  
Increase (Decrease) in Stockholders' Equity          
Vested restricted stock awards $ 1 4   $ (4) 1
Vested restricted stock awards (in shares) 519,218     3,730  
Stock-based compensation   81     81
Stock awards to Board of Directors (in shares) 97,275        
Net Income (Loss)     (5,887)   (5,887)
Balance at Sep. 30, 2023 $ 19 $ 955,630 $ (988,768) $ (2,154) $ (35,273)
Balance (in shares) at Sep. 30, 2023 19,167,971     129,515 19,167,971